Delivery Order SPE2DB22D3501-SPE2DB24FUA08
- Not listed
- This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vial, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,108.26 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 21, 2026, with performance to be fulfilled from the awardee's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite...
- The Defense Logistics Agency awarded a $9,829.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract is a non-set-aside award with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.39 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on November 18, 2025, with completion targeted for November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through DLA's pharmaceutical procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $5,532.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which is not set aside for any specific business category, represents a competitively awarded transaction with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of Cencora, Inc.) on January 27, 2026, for the supply of Ferumoxytol 510 mg/17 mL vials valued at $2,615.80, with completion expected by January 28, 2026. The award utilizes a firm fixed-price structure with no set-aside designation, indicating full and open competition. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, the headquarters of...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a contract ceiling value of $10,059.24. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was made without set-aside restrictions, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a $13,523.28 delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, particularly in patients with chronic...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUA08Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to deliver Ferumoxytol 510 mg/17 ml vial medication. The $10,892.08 firm fixed price delivery order has a completion date of January 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken, Pennsylvania. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is an experienced government contractor, having received numerous prior DLA Troop Support Medical awards to supply pharmaceuticals, medical supplies, and distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 12/29/23 |